Search
  • Within this site
AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
Back to search results

Analgesic composition of topically applied nonsteroidal antiinflammatory drugs and opioids


Summary

The attractiveness of this combinations is their propensity to suppress the expression and function of proteins involved in inflammatory and neuropathic pain and in the same time to activate the antinociceptive mu opiod system involved in pain relief. Targeting the different system, pro-nociceptive and anti-nociceptive, result in summation of the analgesic effects.




Technology Benefits

The European neuropathic pain market is characterized by a particularly high level of unmet need for effective therapeutics due to the under-utilization of anti-depressants, the lack of opioid availability, commonly used to treat neuropathic pain in the U.S. and certain European country-markets, but not others. This under-utilization stems primarily from a lack of awareness about the potential utility of these drugs in neuropathic pain treatment and concerns about opioid addiction. By 2015, the


Application No.

US20080449912


Coverage Areas

Germany, UK, France, Italy, Sweden, Swiss,Ireland, Canada, 13. Pending USA, India


Goods and Services

Sale, License agreement


Patent Information

Issued patent


Country/Region

Denmark

For more information, please click Here
Business of IP Asia Forum
Desktop View